. (1984). Toxico/. App/. Pharmaco/. 73,[373][374][375][376][377][378][379][380][381][382][383][384][385][386][387]. It was the aim oftbis investigation to determine whether covalent binding of di(2.ethylhexyl) phthalate (DEHP) to rat liver DNA and of di(2-ethylhexyl) a(iipate (DEHA) to mouse liver DNA could be a mechanism of action contributing to the observed induction of liver tumors after lifetime feeding of the respective rodent species with high doses of DEHP and DEHA. For this purpose, DEHP and DEHA radiolabeled in different parts of the molecule were administered orally to female rats and mice, respectively, with or witbout pretreatment for 4 weeks with 1% unlabeled compound in the diet. Liver DNA was isolated after 16 hr and analyzed for radioactivity. The data were converted to a covalent binding index, CBI = (micromoles of substance bound per mole of DNA nucleotides)/(millimoles of substance applied per kilogram body weight), in order to allow a quantitative comparison also with other carcinogens and noncarcinogens. Administration of C]hexanol perfonned with both rats and mice allowed the conclusion tbat most if not all DEHA radioactivity in mouse liver DNA was due to biosynthetic incorporation. A maximum possible true DNA binding by DEHA must be below CBI 0.01. Pretreatment of the animals witb unlabeled compound bad no effect on the DNA radioactivities in either species. The present negative data, in conjunction witb other negative short-term tests for mutagenicity, strongly indicate that covalent interaction with DNA is highly unlikely to be the mode of tumorigenic action of DEHP and DEHA in rodents.
The plasticizer di(2-ethylhexyl) phthalate (DEHP) was reported to induce liver tumors in F344 rats and B6C3Fl mice in a 2-year feeding experiment (National Toxicology Program, 1982a) . The doses used (12,000 and 6000 ppm DEHP in the diet for the rats and 6000 and 3000 ppm for the mice) caused increased incidences of hepatocellular carcinoma or neoplastic nodules in female rats of either dose group and in male rats of the high er dose group as well as hepatocellular carcinoma and adenoma in mice of either sex and dose group.
Di(2-ethylhexyl) adipate (DEHA) was reported to induce liver tumors in mice in a 2-year feeding experiment with 12,000 ppm and 25,000 ppm DEHA admixed to the diet (National Toxicology Program, 1982b) . Increased incidences of hepatocellular adenoma and carcinoma in males and females were found in either dose group. In rats, no difference in incidence or type of tumors between treated and control animals was observed after a 2-year feeding with 12,000 or 25,000 ppm DEHA in the diet.
Considering the widespread use of DEHP and DEHA and the possible exposure of the generat population to low doses, it seems important to determine whether the tumor·in-ducing potential of these compounds is based upon a genotoxic mode of action via DNA binding or whether other mechanisms are responsible. The answer is essential for any ex .. trapolation between species and from high to low doses.
DEHP and DEHA are inducers of peroxisomes in rats (Moody and Reddy, 1978; Reddy, 1981; Mangham et al., 1981; Gray et al., 1982) . The peroxisome inducers may form a novel class of carcinogens (Reddy et al., 1980) . On the other band, data on a putative interaction of radiolabeled DEHP with rat liver DNA in vivo have been presented by Albro et a/. ( 1982) . In a subsequent report (Albro et al., 1983) which inch.ided data on dual Iabel experiments, this group presented indirect evidence that the association of radiolabel with DNA might have been due to biosynthetic incorporation. The main limiting factor in their studies was the fact that the low Ievel ofDNA radioactivity allowed no analysis of the DNA constituents to distinguish between biosynthetic incorporation of the ra· diolabel and true covalent deoxyribonucleotide-DEHP adducts.
These preliminary findings prompted us to perform a DNA-binding assay with DEHP in rat and mouse Ii ver and :pEHA in mause Ii ver. Large amounts of radioactivity were administered in our study in order to achieve sufficiently high specific activities in the DNA to allow for an analysis of the source of the radiolabel and to irnprove the Iimit of detection in case of a negative result. The present study was carried out with DEHP and DEHA radioactively labeled in three different positions as illustrated in Fig. 1 . A
14
C Iabel was introduced either at the carboxylate carbon atom of the phthalate moiety (I) or at C -1 of the alcohol moiety of DEHP (II) and of DEHA (V). titative changes in the enzymatic drug metabolism pattem. In order to investigate whether such pretreatment could have an effect on DNA binding, groups of animals were pretreated for 4 weeks with a diet containing 10 gjkg DEHP or DEHA. given ad /ibitum. Feed consumption was measured daily.
METHODS
The body weight was monitored weekly.
After 2 to 3 weeks of acclimatization, one group of animals was given the DEHP-or DEHA-containing diet for 4 weeks while the others received the regu1ar chow. The radiolabeled test compounds were then administered by oral gavage of the solutions described above on dose Ievels indicated in the tables. For each experiment two animals served as unlabeled controls and were treated with no radioactivity at all.
Pharmacokinetics. After the administration of the radiolabeled compounds, the animals were held in all-glass metabolism cages, and urine was collected. An air stream of 0.4 Iiterimin transported the expired air to a trap with ethanolamine:methanol 1 :4 to collect the 14 C0 2 expired.
The production oftritiated water, HTO, from [ 3 H]DEHP was determined on the basis of the specific activity of the HTO in the urine after dilution with water and repeated recondensation.
Isolation of DNA. Sixteen hours after the administration of the radiolabeled compounds, the animals were killed by open heart puncture under ether anesthesia, and livers were excised and weighed. A crude chromatin fraction was prepared in the cold by a slightly modified method described by Yaneva and Dessev (1976) : The liver was homogenized in 75 mM NaCl, 10 mM EDTA, 10 mM Tris/HO, pH 7.8, in a Potter-Elvehjem homogenizer. Nonidet P-40 detergent was added to a concentration of 0.2%. After 15 min, the samples-were centrifuged for 5 min at 700g. The crude chromatin pellet was washed once with 10 mM EDT A, I 0 mM Tris/HO, pH 7 .8. The isolation and purification of DNA from chromatin at room temperature followed the standard method used in our laboratory, which is based on a method of two extractions with phenol:chloroform:isoamyl alcohol 25:24:1 and a hydroxylapatite column chromatography as the main purification step (Markov and lvanov, 1974) . After dialysis against water at 4 °C o~ernight, addition of Naa t~ a concentration of 0.2 M and precipitation after addition of a twofold volume of ethanol, the DNA was dried on an aspirator vacuum and dissolved in 4 or 5 ml of I 0 mM Tris/HO, 10 mM MgCh, pH 7.0. In the experiment with mice the ethanol precipitation step was repeated once. The DNA content was determined on the basis of a uv absorbance of 20 at 260 nm for a solution of l mg/ml. An aliquot of 1 ml was used for radioactivity counting. If no radioactivity was measurable, the remaining DNA solution was added to the vial and counted again. If radioactivity was detectabJe on a Ievel of at least 50 cpm/ mg, DNA was degraded enzymatically or depurinated with hydrochloric acid, and the deoxyribonucleosides or purine bases were separated by HPLC to determine biosynthetic incorporation of radioactivity into the DNA. mm, Knauer, Oberursel, FRG) and eluted with a flow of 3.5 ml/min for 56 min with a methanol:water gradient 0-10% for the first 5 min, 10-100% from 10 to 50 min. The optical density at 254 nm of the eluate was continuously recorded in a ßow photometer (Perkin-Elmer LC55). Fractions of 7 ml were collected (unless indicated otherwise in fig. 7 ) and added to 10 mi Insta-Gel (Packard) for radioactivity counting.
Determination of covalent binding indices (CBI
The background radioactivity in the 14 C channel was determined for each chromatogram on the basis of mean and standard deviation of fractions 1 and 11-28. The background radioactivity in the 3 H channel is not constant over the entire chromatogram due to the quenching by a higher methanol content in the later fractions. The background radioactivity of the first 12 fractions and the respective standard deviation were therefore detennined with linear regression of the cpm values of fractions 1, 3, 4, 8, 9, 11, and 12. The background radioactivity of fractions J 3-28 was detennined on the basis ofthe mean and standard deviation of these single fractions obtained from control DNA.
Analysis of purine bases. The DNA was depurinated by acid hydrolysis. HO ( 1 M) was added to the DNA solution to give a concentration of 0.1 M. The samples were incubated for 1 hr at 70°C (Meier-Bratschi et a/., 1983) . After the samples were fittered through 0.22-pm filters, they were loaded onto an HPLC reverse-phase column, ~ndapack C 18 (7.8 X 300 mm, Waters), and eluted with 3.5 ml/min 0.01 M ammonium phosphate, pH 4, with 1% methanol. The elution was monitared at 254 nm. Two-minute fractions of 7 ml were collected and added to 10 mllnsta-Gel for radioactivity counting.
The background radioactivity in the 14 C and 3 H channels was determined for each chromatogram on the basis of the mean and standard deviation of fractions l, 4, 5, 7, 8, and 10-27. Seinti/laiion counting: Statistics. The radioactivity counting was carried out in a liquid scintillation counter, Tri-Carb 460 CD (Packard), with Insta-Gel (Packard) as the scintillation mixture. For small amounts of radioactivity, the samples were counted 4 X 40 min. The background was determined as the mean count of two DNA samples isolated tagether with the test samples from animals which bad not received radiolabels but which were held tagether with the test animals. These values, given in the tables and figures, varied between the experiments with standard deviations of ± 1.1 cpm and ±0.8 cpm in the 1 4(: and 3 H channels, respectively (statistical mean of standard deviations within each pair ofbackground counts) (Kaiser, 1965) . This standard deviation was also used to decide whether significant radioactivity was detected in the vial containing DNA oftreated animals. The counting efficiencies varied with the quench grade of the samples and were determined with intemal standards. They are given in footnotes to the tables.
RESULTS

General Observations and Pharmacokinetic Parameters
In the rat. Feed consumption did not differ between the pretreated and the nonpretreated rats. The daily feed intake in the respective groups was 12.2 ± 1.2 and 13.8 ± 2.1 g per rat, resulting in a DEHP dose for the pretreated rats of 0.65 ± 0.05 gfkg body wt per day. No deviation from the normal body weight gain known for this strain was observed.
The pretreatment of rats with DEHP in the feed (10 g/kg) for 4 weeks increased the liver weight to body weight ratio significantly, a finding which is in accordance with other reports (Carpenter et al., 1953; Harris et a/., 1956; Moody and Reddy, 1978) . It was 56.2 ± 2.4 g/kg body wt compared to 41.3 ± 3.9 g/kg body wt of the nonpretreated rats. The liver enlargement resulted in a more rapid metabolism of the subsequent dose of radiolabeled DEHP as is illustrated by the more rapid and more extensive exhalation of About one-third of the radioactive dose of all four compounds was excreted within 16 hr in the urine. By taking into account the additional metabolites still present in the body, it is reasonable to assume that at least half the dose had been absorbed from the gastrointestinal tract and passed the liver.
Exhalation of 14 C0 2 by the rats treated with the carboxylate-Iabeled DEHP I accumulated within 16 hr to less than a fraction of 3 X 1 o-s ofthe radioactivity administered (Fig. 2 ). This finding is so small tbat it does not have to be the result of a metabolic cleavage of the carboxylate carbon of DEHP I from its benzene moiety, but could be due to radiolabeled impurities. The 14 C02 exhalation after administration of a/coho/-Iabeled DEHP ß is, however, in the order ofa few percent ofthe dose (Fig. 3) . DEHP pretreatment resulted in an increased production of t 4 C0 2 • After administration of l-t 4 C-labeled 2-ethylhexanol IV, the fraction of expired 14 C0 2 represented as much as 15% (Fig. 4) .
In the mouse. Feed consumption was slightly but not significantly increased in DEHA-pretreated mice. The daily feed intake in the respective groups was 7.12 ± 1.75 and 5.44 ± 0.84 g per mouse, resuJting in a DEHA dose for the pretreated mice of 2.09 ± 0.57 [lH]DEHA was determined on the basis of the specific activity ofHTO in the urine, which was between 1 and 4 X 10 7 dpm/ml. Under the assumption that HTO is distributed homogeneously in the body fluid and that the total water content of a mouse is 60% of its body weight, 3 and 1.5% ofthe dosebad been released as HTO in pretreated and nonpretreated animals, respectively. The 14 C0 2 exhalation after administration of 14 C-labeled DEHA, DEHP, and EH was in the order ofa few percent ofthe dose. DEHA pretreatment resulted in an increased production of 14 C02. The exhalation of 14 C0 2 after administration of P 4 C]EH was more rapid than that of DEHA and was more extensive (Fig. 5) .
The pretreatment of mice with DEHA in the food ( 10 g/kg) for 4 weeks increased the liver weight to body weight ratio slightly but not significantly. It was 78 ± 24 g/kg body wt as compared to 61 ± 14 g/kg body wt of the nonpretreated mice. The more rapid metabolism of the radiolabeled DEHA, illustrated by an increased exhalation of 14 C0 2 , a more rapid excretion of radiotabei in the urine, and an increased HTO production, is probably due to this liver enlargement.
,, 
DNA-Binding Studies in the Rat
The data on the radioactivity determined in the DNA are summarized in Table 1 . With carboxylate-labeled DEHP I, minute radioactivity could be detected in only one of four DNA samples. In all other samples, irrespective of the DEHP pretreatment, the radioactivity was below the. Iimit of detection of the order of 0.02 CBI unit. In one case, a small amount of radioactivity was detected in the DNA. lt is very unlikely that this radioactivity originated from a radioactive labeled DNAphthalate adduct. Probably it is noncovalently bound radioactivity from contaminating protcins or labeled metabolites which may not have been completely removed in this specific sample. Our negative finding is in accordance qualitatively with that of Albro et al. ( 1982) who also did not find any radioactivity in the DNA after oral administration of carboxylatelabeled [ 14 C]DEHP. Due to the fact that they administered only about 6.6 X 10 8 dpm/kg, i.e., about 20 times less than the dose used in our study, their finding is Iess valuable, however, on a quantitative basis for an exclusion of a genotoxic activity.
When the Iabel was in the alcohol moiety (DEHP II and 111), radioa~tivity was easily detected in all samples, regardless of whether the Iabel was The radioactivity associated with the DNA samples could be due to noncovalent interaction of the compound or some metabolite with DNA, to biosynthetic incorporation of radiolabeled precursors of DNA synthesis, or to true covalent adducts with DNA. Contamination of the DNA with radiolabeled protein cannot contribute substantially to the DNA radioactivity because the specific activity of chromatin protein was only about 50 times In the experiment with compound IV, the calculation of net radioactivity is based on baclcground activities of 13.6 and 13.7 cpm for Ii ver DNA isolated from two untreated animals. The counting efficiency was 76.4%. higher than that of DNA which is known to be contaminated by a maximum of0.2% protein (Sagelsdorff et al., 1983) .
The relatively high 14 C0 2 production seen after administration of DEHP II and EH IV indicates that a large fraction of the alcohol moiety is degraded in the body. The degradation products may then be used as precursors in the biosynthesis of the deoxyribonucleosides. After oral administration of (Table 1 ) .
The 3 H radioactivity in the DNA measured after the administration of [ 3 H]DEHP 111 was about 12 times lower than the 14 C radioactivity originating from DEHP II. Again, this radioactivity was shown to result primarily from biosynthetic incorporation into DNA of tritiated breakdown products produced during the Oxidation ofthe Iabeted hexanol. Tritiated water was also shown to be formed and the specific activity of HTO in the 16-hr urine was about 2 X 10 7 dpm/ml. Control experiments with oral administration of HTO and isolation of liver DNA after 24 hr revealed that radiolabel is associated with the DNA on an apparent CBI Ievel of 0.5 (Lutz, 1979) . This radioactivity is not lost from the DNA upon washing so that it does not represent simple proton-tritium ion exchange. One possibility for the formation of a stable carbon-tritium bond is given for instance by the reduction of the 2'-hydroxyl group of the ribonucleoside diphosphate to the 2'-deoxy derivative of DNA. A quantitative comparison similar to the one calculated above with the 14 C Iabel is rendered more complicated, however, because the HTO formed in the liver cell from oxidative metabolism of DEHP 111 reaches a higher intracellular concentration as compared with HTO distributed uniformly after oral administration.
Although the above discussion clearly indicates that 14 C and 3 H radioactivities in the DNA isolated after administration of alcohollabeled DEHP ß and 111 can be explained by reasons other than covalent interaction of reactive metabolites, this hypothesisbad tobe corroborated on the basis of an analysis of DNA constituents.
Analysis of nucleosides. An analysis of de-
oxyribonucleosides was carried out with the DNA obtained from rats treated with 14 C-and 3 H-labeled DEHP II and ßl and 14 C-labeled EH IV. The elution of the natural deoxyribonucleosides localized by their optical density at 254 nm was the same for a1l DNA samples and is shown on the bottom of Figs. 6 and 7. Retention times of 8.5 min for deoxycytidine (dC), 11.5 min for deoxyguanosine (dG), 13.5 min for thymidine (T}, and 18 min for deoxyadenosine (dA) were recorded. The peak appearing at 10.0 min represented deoxyinosine ( dl) which was formed in variable amounts during the hydrolysis of the DNA by enzymatic deamination of deoxyadenosine by enzyme impurities. Figure 6 shows the elution of the 14 C and 3 H radioactivity of the digested DNA of animals that had been given alcohol-labeled DEHP (II plus 111). lt can readily be seen that no radioactivity elutes after deoxyadenosine, i.e., in the region known to contain the more lipophilic deoxyribonucleoside-carcinogen adducts, derived for example from benzo-
[a]pyrene (Jennette et a/., 1977; Boroujerdi et al., 1981 ) , dimethylbenz [a] anthracene (Jeffrey et a/., 1976) , or 3-methylcholanthrene (King et al., 1977) . Radioactivity eluted exclusively with the front peak and with natural nucleosides. The fractions containing the natural nucleosides amounted to the largest part of the total radioactivity eluted, representing 87 to 97% 14 C and 42 to 69% 3 H. If these radioactivities, clearly due to biosynthetic incorporation of radiolabeled DEHP-breakdown products, are deducted from the total apparent CBI as given in Table I , residual values ofO.l to 0.5 and 0.2 to 0.3 for 14 C and 3 H, respectively, result. This view is the most conservative approach based on the assumption that the front peak is due to some sort of DNA adduct fonned by the alcohol moiety of DEHP.
These front fractions, No. 2 plus No. 3 of the deoxyribonucleoside chromatograms, contained 3-13 and 31-58% of the 14 C and 3 H radioactivity, respectively. Such early eluting radioactivity is generally observed in HPLC analyses ofDNA degradation products. It could be due to tightly but noncovalently bound DEHP metabolites, including tritiated water, released from the DNA only after breakdown to the nucleosides. It is also possible that it contains oligo-nucleotides formed by incomplete enzymatic degradation, or sugars produced from degradation of apurinic acid. The latter DNA fragments could have their radioactivity from either biosynthetic incorooration or covalently bound test substance.
The same Situation was observed with (Fig. 7) . After deduction of the biosynthetic incorpomtion of radiolabet (83 to 90% of the total specific activity), a maximum possible CBI of 0.6 to 0.9 could result. In this experiment all deoxyadenosine bad been converted to deoxyinosine.
Another way of estimating maximum possible CBI could be based upon the general assumption that carcinogen-deoxyribonucleoside adducts are expected to elute only after 20 min in the region of fractions 11-28, due to a higher lipophilicity of such adducts. No· Analysis of purines. The above discussion is based upon the general knowledge that nucleoside adducts of typical genotoxic carcinogens such as benzo[a]pyrene, dimethylbenz [a]anthracene, or 3-methylcholanthrene elute after the natural nucleosides, due to increased lipophilicity. It is possible that smaller adducts such as methylated or ethylated nucleosides would not elute much later than the parent natural nucleoside. Therefore, a purine base analysiswas performed after acid hydrolysis of two DNA samples of two anirnals treated with DEHP II plus 111, one each with and without DEHP pretreatment. The HPLC system chosen was known to separate 7 -methylor 7-ethylguanine, the mostabundant alkylation products in DNA, from their parent base. The elution profile is shown in Fig. 8 
DNA-Binding Studies in the Mouse
The data on the radioactivity determined in the mouse liver DNA are surnmarized in 
S:
"The radioactivity in the DNA is expressed in CBI units. 
C and
3 H label, respectively. Although radioactivity in the DNA was detectable in all experiments, the specific activ .. ities were minute (<50 dpm/mg DNA for 3 H and <38 dpmjmg for 14 C) after administration of extremely large doses of radioactivity (>5 X 10 11 and >7 X 10 10 dpm/kg body wt, re . . . spectively). It was therefore useless todegrade the DNA to nucleosides or bases because the HPLC analysis would not have allowed the determination of the fraction of radioactivity which was incorporated into DNA via biosynthesis. The only possibility for a quantitative estimation ofthat source ofradioactivity was by measuring the formation of 14 C0 2 and HTO. The C0 2 data compiled in Fig. 5 show that the DNA radioactivities were proportional to the initial rate of expiration of 14 C Iabel. This finding is a good indication that biosynthetic incorporation of radiolabeled breakdown products was the main reason for the DNA labeling.
The experiment with alcohol-labeled
C]DEHP II in the mousewas performed to establish a link to the results obtained with rats. There, the radioactivity in the liver DNA expressed in CBI units was about 3 as opposed to the mean value of0.05 for mouse (Tables  1 and 2) . The difference by a factor of about 60 is due first to a species difference of about one order of magnitude for biosynthetic incorporation of 14 C0 2 into Ii ver DNA as found earlier in control experiments with oral administration of [ 14 C]methanol to mice and rats (data not shown), and second, to the fact that the production of 14 C0 2 was about twice as high in the rat. The speciftc activity of the liver DNA isolated from the rats was high enough to allow proof that the natural deoxyribonucleosides were radiolabeled (Fig. 6) .
The DNA radioactivity measurable on the liver DNA of mice treated with [ 14 C]DEHP II is therefore most likely also due to biosynthetic incorporation of radiolabeled breakdown products into DNA. The same argument holds for the results obtained after administration of [l 4 C]EH IV. The tritium radioactivity in the DNA measured after the administration of [ 3 H]DEHA VI was three to five times lower than the 14 C radioactivity originating from DEHA V if the specific activities are normalized to the dose administered by using CBI units. Again, the tritium radioactivity could result from biosynthetic incorporation into DNA oftritiated breakdown products, produced during the Oxidation of the labeled hexanol. Tritiated water · was shown to be formed and the specific activity of HTO in urine was between l and 4 X 10 7 dpmjml. This Ievel could be achieved from an oxidation and release of 1 to 4% of the 3 H activity administered. This fraction is in good agreement with the fraction of the 14 C radioactivity expired in the. form of co2. Control experiments with oral administration of HTO to mice and isolation of Ii ver DNA after 24 hr revealed that radiolabet is indeed incorporated in the natural deoxyribonucleosides on an apparent CBI of 0.05 (Sagelsdorff, 1982) . A quantitative comparison sirnilar to the one performed above with the 14 C Iabel is rendered more complicated, however, because the HTO formed in the liver cell from oxidative metabolism of DEHA II will reach a higher intracellular concentration compared to HTO distributed uniformly after oral administration.
lf all the evidence presented above is taken into account, there is little doubt that negligible or none of the DNA radioactivity detected after administration of { C]hexyl) phthalate, they did measure radioactivity in both types of nucleic acids and the radioactivity in RNA was very similar to the value measured after administration of [ 14 C]EH. This contrast is not readily explained since both nucleic acids contain the same nucleophilic centers, and the biosynthetic incorporation into RNA is unlikely to change so drastically from one experiment to another. We canoot explain their findings.
The subsequent report published by this group (Albro et a/., 1983) does not provide any clue to solve the above controversy, but their new findings with alcohol-dual-labeled DEHP at least allowed the conclusion that the intact 2-ethylhexanol side chain cannot simply be attached to DNA. They showed, in addition, that urea isolated from the urine was 14 C-labeled, suggesting that the DNA could have been radiolabeled via biosynthesis.
Jnfluence of the Pretreatment
The specific activity of DNA, most if not all due to biosynthetic incorporation of radiolabeled breakdown products, was not affected by DEHP pretreatment of the rats or by DEHA pretreatment oftbe mice for 4 weeks with 1% in the diet .. The liver weight, on the other band, was increased after pretreatment. This finding means that DNA synthesis per unit Ii ver weight was no Ionger stimulated after 4 weeks but seemed to be in stationary phase no different from controls.
The fraction of the radioactivity dose exhaled in the form of 14 C02 was larger after pretreatment by factors of 1.4 (DEHP I), 2.1 (DEHP II), and 1.5 (DEHA V). The Ii ver was enlarged by factors of 1.5 (DEHP I) and 1.4 (DEHP II) in the rat and 1.3 (DEHA V) in the mouse. The metabolic activity per unit liver weight therefore did not increase at all or only to a very small extent. DEHP therefore seems not tobe an effective inducer of its own metabolism. This finding confirms indirectly other data which show that peroxisomes can be induced without a marked effect on some cytochrome P-450-dependent activities (Walseth et al., 1982) .
The Cova/ent Binding Index
The expression of a DNA binding normalized by the dose in the units ofthe covalent binding index, CBI, was introduced in 1977 (Lutz and Schlatter, 1977a) for a comparison of the DNA-binding activities of various chemieals tested in a nurober of laboratories under widely different conditions. The values measured so far span about five orders of magnitude, ranging from more than 10 4 [aflatoxin 8 1 (Lutz et a/., 1980) ] down to about one [e.g. benzene (Lutz and Schlatter, 1977b) ].
CBis have been shown to reflect very roughly the genotoxic potency of a chemical. CBis of the order of 10 3 to 10 4 are found with potent carcinogens, of around 1 ()2 for moderate carcinogens, and of 1 to 10 for weak carcinogens with a genotoxic mode of action. A plot of the CBI in the target organ as a function of the respective tumorigenic potency in TD50 units derived from long-term bioassays on carcinogenicity has been set up with 13 chemieals for which both values were published (Lutz, 1982a) . The surprisingly high correlation coefficient of0.74 calculated from a linear regression analysis therefore seems to allow placement of a test compound into a category according to the importance of DNA binding as one factor contributing to the overall tumorigenicity.
Our results allow the conclusion that the liver DNA-binding ability of DEHP in rats and of DEHA in mice must be well below a value of 0.05, expressed in CBI units. This is almost one million times below the genotoxicity of aflatoxin B 1 , where daily doses of as little as 1 o-s mmol/kg resulted in detectable tumor formation. If the much lower maximum possible DNA binding by DEHP and DEHA should become responsible for a positive result in a rodent bioassay on. carcinogenicity, impossibly high doses or an unrealistically large number of animals would be required if the correlation of carcinogenic potency to DNA binding is extrapolated to a CBI value of 0.05 (Lutz, l982a) .
The fact that a tumorigenicity of DEHP and DEHA has clearly been demonstrated, however, is an indication that activities other than DNA binding ofthe test compound must be responsible. The observation that induction of peroxisomes is associated with increased hepatic tumor formation (Reddy et a/., 1980) and the finding of an excessive accumulation of autofluorescent lipofuscin in the Ii ver during bepatocarcinogenesis by peroxisome proliferators (Reddy et al .• 1982) led these authors to the bypothesis that persistent proliferation of peroxisomes and increase in peroxisomal ß-oxidation systems could serve as an endogenous initiator of the neoplastic transformation ofliver cells by increasing the intracellular production ofDNA-damaging H20 2 and other reactive oxygen intermediates.
A DNA-binding assay in vivo finds an important application where a long-term assay on carcinogenicity was clearly positive, but where additional infonnation, such as mutagenicity data, renders a genotoxic mode of action via DNA binding unlikely (Lutz, 1982b) . These requirements are met with DEHP and DEHA. Here, it was important to verify the Iack of DNA binding of the compound also in a mammalian organism. Negative results as shown above suggest that the tumorigenicity might have been dependent on the onset of some type of biological response which should also have been observable in the bioassay. With DEHP and DEHA, this response could well be the proliferation of peroxisomes. For an assessment of the risk for man from exposure to this type of carcinogen, it will therefore be important to establish doseeffect relationships and to further substantiate the importance of species differences.
